Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Undisclosed GA Program 1
- Development stage
- Preclinical
- Lead developer
- Clearside Biomedical
- Modality
- Small Molecules
- Administration
- Ophthalmic, Suprachoroidal Injection
01
Overview
Undisclosed GA Program 1 is a preclinical small molecule drug candidate being developed by Clearside Biomedical for the treatment of Geographic Atrophy (GA), an advanced form of dry age-related macular degeneration. The therapeutic approach focuses on modulating choroidal perfusion, aiming to improve blood flow to the outer retina and retinal pigment epithelium, which are typically compromised in patients with GA. The drug is designed for delivery into the suprachoroidal space (SCS) using Clearside's proprietary SCS Microinjector technology. This delivery method is intended to provide high concentrations of the drug to the affected posterior tissues of the eye while minimizing exposure to the anterior segment, potentially improving the safety and efficacy profile compared to traditional intravitreal injections.
- Other names
- Clearside GA Program 1Choroidal perfusion modulator program
Beyond the preview
Go deeper on Undisclosed GA Program 1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Undisclosed GA Program 1.